Pharmacology · Pathway 10
Aspirin
Key points
- Aspirin irreversibly blocks COX-1 and COX-2 → ↓ thromboxane A2 in platelets → ↓ platelet aggregation.
- MHRA 2010 reminder: aspirin is NOT licensed for primary prevention of cardiovascular disease.
- Established indications: secondary prevention — stroke, TIA, IHD, PVD (unless contraindicated).
- Potentiates oral hypoglycaemics, warfarin and steroids.
- Aspirin can be continued normally for dental procedures.
Decision points in this pathway
- Primary or secondary prevention?
The full step-by-step algorithm, including what to do at each branch, opens in the app for approved members.